NCT00294216View on ClinicalTrials.gov

Omacor and Placebo in Carotid Plaque Stability

PHASE3CompletedINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

July 31, 2005

Conditions

Cardiovascular Disease

Interventions

DRUG

Omega-3-acid ethyl ester 90 (n-3 PUFA)

Trial Locations (1)

SO17 1BJ

University of Southampton, School of medicine, Southampton

Sponsors

Lead Sponsor

Pronova BioPharma

All Listed Sponsors

lead

Pronova BioPharma

INDUSTRY

NCT00294216 - Omacor and Placebo in Carotid Plaque Stability | Biotech Hunter | Biotech Hunter